{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibcwwkhhqzqv46tz3fhp5s2trcpaqx74ykktoliskhxxijcxdhmxu",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mfbauegh5g42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih2j6cus6gmj2q3eh7f23mskxjoqy2fxo3h3wtnao4hto3jcncpsq"
    },
    "mimeType": "image/jpeg",
    "size": 188539
  },
  "path": "/2026/02/19/grail-cancer-test-galleri-results/?utm_campaign=rss",
  "publishedAt": "2026-02-19T22:38:45.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "Cancer",
    "diagnostics",
    "STAT+"
  ],
  "textContent": "Grail's blood test for detecting cancer early failed to meet its main goal in a giant study being conducted with England’s NHS, the company said.",
  "title": "STAT+: Key study of Grail’s cancer detection test fails in setback for company",
  "updatedAt": "2026-02-20T01:37:14.000Z"
}